Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome

Eye (Basingstoke)

Volumn 28, Issue 4, 2014, Pages 390-398

  Monteiro, M L R ^a   Afonso, C L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

macular thickness measurements; optical coherence tomography; papilledema; pseudotumor cerebri syndrome

Indexed keywords

ADULT; ANALYZER; ARTICLE; BRAIN PSEUDOTUMOR; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; MACULAR THICKNESS; MALE; OPTICAL COHERENCE TOMOGRAPHY; PAPILLEDEMA; PERIMETRY; RETINAL NERVE FIBER LAYER THICKNESS; VISUAL IMPAIRMENT;

ADULT; AXONS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; PAPILLEDEMA; PROSPECTIVE STUDIES; PSEUDOTUMOR CEREBRI; RETINAL GANGLION CELLS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL FIELDS;

EID: 84898484380     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2013.301     Document Type: Article

References (43)

1. Danesh-Meyer HV, Carroll SC, Foroozan R, Savino PJ, Fan J, Jiang Y et al. Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression. Invest Ophthalmol Vis Sci 2006; 47: 4827-4835.
2. Monteiro ML, Cunha LP, Costa-Cunha LV, Maia Jr. OO, Oyamada MK. Relationship between optical coherence tomography, pattern electroretinogram and automated perimetry in eyes with temporal hemianopia from chiasmal compression. Invest Ophthalmol Vis Sci 2009; 50: 3535-3541.
3. Monteiro ML, Leal BC, Moura FC, Vessani RM, Medeiros FA. Comparison of retinal nerve fibre layer measurements using optical coherence tomography versions 1 and 3 in eyes with band atrophy of the optic nerve and normal controls. Eye (Lond) 2007; 21: 16-22.
4. Monteiro ML, Fernandes DB, Apostolos-Pereira SL, Callegaro D. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53: 3959-3966.
5. Barboni P, Savini G, Parisi V, Carbonelli M, La Morgia C, Maresca A et al. Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age. Ophthalmology 2011; 118: 2076-2080.
6. Hedges 3rd TR, Legge RH, Peli E, Yardley CJ. Retinal nerve fiber layer changes and visual field loss in idiopathic intracranial hypertension. Ophthalmology 1995; 102: 1242-1247.
7. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39: 461-474.
8. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114(Pt 1A): 155-180.
9. Binder DK, Horton JC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery 2004; 54: 538-551, discussion 51-52.
10. Fraser C, Plant GT. The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension. Curr Opin Neurol 2011; 24: 12-17.
11. Orcutt JC, Page NG, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984; 91: 1303-1312.
12. Wall M, George D. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol 1987; 44: 170-175.
13. Monteiro ML. Visual loss in pseudotumor cerebri. Arq Bras Oftalmol 1994; 57: 122-125.
14. Savini G, Bellusci C, Carbonelli M, Zanini M, Carelli V, Sadun AA et al. Detection and quantification of retinal nerve fiber layer thickness in optic disc edema using stratus OCT. Arch Ophthalmol 2006; 124: 1111-1117.
15. Scott CJ, Kardon RH, Lee AG, Frisen L, Wall M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 2010; 128: 705-711.
16. Skau M, Milea D, Sander B, Wegener M, Jensen R. OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 2011; 249: 723-730.
17. El-Dairi MA, Holgado S, O'Donnell T, Buckley EG, Asrani S, Freedman SF. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS 2007; 11: 564-570.
18. Kaufhold F, Kadas EM, Schmidt C, Kunte H, Hoffmann J, Zimmermann H et al. Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS One 2012; 7: e36965.
19. Guedes V, Schuman JS, Hertzmark E, Wollstein G, Correnti A, Mancini R et al. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology 2003; 110: 177-189.
20. Medeiros FA, Zangwill LM, Bowd C, Vessani RM, Susanna Jr. R, Weinreb RN. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol 2005; 139: 44-55.
21. Sung KR, Wollstein G, Kim NR, Na JH, Nevins JE, Kim CY et al. Macular assessment using optical coherence tomography for glaucoma diagnosis. Br J Ophthalmol 2012; 96(12): 1452-1455.
22. Costa-Cunha LV, Cunha LP, Malta RF, Monteiro ML. Comparison of Fourier-domain and time-domain optical coherence tomography in the detection of band atrophy of the optic nerve. Am J Ophthalmol 2009; 147: 56-63, e2.
23. Moura FC, Medeiros FA, Monteiro ML. Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography. Ophthalmology 2007; 114: 175-181.
24. Monteiro ML, Costa-Cunha LV, Cunha LP, Malta RF. Correlation between macular and retinal nerve fibre layer Fourier-domain OCT measurements and visual field loss in chiasmal compression. Eye (Lond) 2010; 24: 1382-1390.
25. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134: 518-533.
26. Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73: 302-308.
27. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-1495.
28. Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 1982; 45: 13-18.
29. Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology 2000; 107: 1809-1815.
30. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
31. Ney JJ, Volpe NJ, Liu GT, Balcer LJ, Moster ML, Galetta SL. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology 2009; 116: 1808-1813, e1.
32. Waisbourd M, Leibovitch I, Goldenberg D, Kesler A. OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg 2011; 113: 839-843.
33. Rebolleda G, Munoz-Negrete FJ. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci 2009; 50: 5197-5200.
34. Salgarello T, Falsini B, Tedesco S, Galan ME, Colotto A, Scullica L. Correlation of optic nerve head tomography with visual field sensitivity in papilledema. Invest Ophthalmol Vis Sci 2001; 42: 1487-1494.
35. Laemmer R, Heckmann JG, Mardin CY, Schwab S, Laemmer AB. Detection of nerve fiber atrophy in apparently effectively treated papilledema in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 2010; 248: 1787-1793.
36. Heckmann JG, Faschingbauer F, Lang C, Reulbach U, Dutsch M, Mardin CY et al. Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension. J Neurosurg 2007; 107: 543-547.
37. Wang JK, Kardon RH, Kupersmith MJ, Garvin MK. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53: 4069-4075.
38. Mulholland DA, Craig JJ, Rankin SJ. Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension. Br J Ophthalmol 1998; 82: 1301-1305.
39. Grzybowski A. The role of antibiotics in the prevention of post-intravitreal anti-VEGF endophthalmitis: primum non nocere! Eye 2014; 28: 500.
40. Ghasemi Falavarjani K, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye 2013; 27: 787-794.
41. Yin VT, Weisbrod DJ, Eng KT, Schwartz C, Kohly R, Mandelcorn E et al. Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol 2013; 131(4): 456-461.
42. Chen RW, Rachitskaya A, Scott IU, Flynn HW. Is the use of topical antibiotics for intravitreal injections the standard of care or are we better off without antibiotics? JAMA Ophthalmol 2013; 131(7): 840-842.
43. Cochereau I, Korobelnik JF, Bodaghi B. Prevention of post intravitreal injection endophthalmitis: is antibioprophylaxis indicated? J Fr Ophtalmol 2013; 36(1): 72-75.